Laboratory Shareholders Equity Per Share from 2010 to 2024

LH Stock  USD 240.63  0.53  0.22%   
Laboratory's Shareholders Equity Per Share is increasing with slightly volatile movements from year to year. Shareholders Equity Per Share is estimated to finish at 94.93 this year. For the period between 2010 and 2024, Laboratory, Shareholders Equity Per Share quarterly trend regression had mean deviation of  27.95 and range of 103. View All Fundamentals
 
Shareholders Equity Per Share  
First Reported
2010-12-31
Previous Quarter
90.41331803
Current Value
94.93
Quarterly Volatility
32.86308488
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.0122 or PTB Ratio of 3.28. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Shareholders Equity Per Share Growth Pattern

Below is the plot of the Shareholders Equity Per Share of Laboratory of over the last few years. It is Laboratory's Shareholders Equity Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
Shareholders Equity Per Share10 Years Trend
Slightly volatile
   Shareholders Equity Per Share   
       Timeline  

Laboratory Shareholders Equity Per Share Regression Statistics

Arithmetic Mean62.71
Geometric Mean52.02
Coefficient Of Variation52.40
Mean Deviation27.95
Median66.70
Standard Deviation32.86
Sample Variance1,080
Range103
R-Value0.96
Mean Square Error95.29
R-Squared0.92
Slope7.04
Total Sum of Squares15,120

Laboratory Shareholders Equity Per Share History

2024 94.93
2023 90.41
2022 110.83
2021 106.23
2020 96.19
2019 77.29
2018 68.75

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Shareholders Equity Per Share, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Shareholders Equity Per Share 90.41  94.93 

Currently Active Assets on Macroaxis

Check out the analysis of Laboratory Correlation against competitors.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
5.28
Revenue Per Share
151.028
Quarterly Revenue Growth
0.074
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.